Resource Center
Resource Center
The report looks at the complex, ever-changing antiretroviral and diagnostic markets in low- and middle-income countries based on aggregated market intelligence from our programmatic work in over 30 countries.
Read moreCancer Access Partnership is expected to result in a 59 percent savings on procured cancer medicines.
Read moreAVAC, CHAI and others are making sure we can introduce a new HIV prevention injection quickly and safely after early results from a clinical trial.
Read moreCEO Iain Barton chats about CHAI's COVID-19 response, what he is bringing to the organization, and setting “big, hairy, audacious goals” for the future.
Read moreAgreement with Omega Diagnostics will help deliver same-day CD4 testing for people living with HIV in over 130 low- and middle-income countries at just US$3.98 per test.
Read morePreclinical work in mice and primates has demonstrated that a single injection of a new drug developed by UNMC is effective in achieving blood drug levels known to be active against HIV for up to one year.
Read moreAt CHAI, our staff is our greatest asset. Our efforts are driven by the talent, creativity, and hard work of our people. This year, for International Women’s Day, we are highlighting several of the women who work at CHAI.
Read moreIra C. Magaziner will continue to work with CHAI as a senior advisor and help drive new CHAI initiatives.
Read moreOur Senior Director for HIV reflects on World AIDS Day: "Although we have had many successes over the past decade in our work in HIV, it is our failures that keep me up at night and push me to do more."
Read more